The IASLC 2024 Hot Topic in Basic & Translational Science: Tolerance & Resistance to Targeted Therapy in NSCLC (HTTR 2024) offers your organization multiple opportunities to engage with basic scientists, translational researchers, and clinicians working to advance the understanding and treatment of non-small cell lung cancer.